Literature DB >> 23545795

The DSM-5 field trials and reliability of alcohol use disorder.

Deborah S Hasin, Marc Auriacombe, Guilherme Borges, Kathleen Bucholz, Alan Budney, Thomas Crowley, Bridget F Grant, Charles O'Brien, Nancy M Petry, Marc Schuckit, Melanie M Wall.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23545795      PMCID： PMC4290854          DOI： 10.1176/appi.ajp.2013.13010032

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  7 in total

1.  DSM-5 field trials in the United States and Canada, Part I: study design, sampling strategy, implementation, and analytic approaches.

Authors:  Diana E Clarke; William E Narrow; Darrel A Regier; S Janet Kuramoto; David J Kupfer; Emily A Kuhl; Lisa Greiner; Helena C Kraemer
Journal:  Am J Psychiatry       Date:  2013-01       Impact factor: 18.112

Review 2.  Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10).

Authors:  Deborah Hasin; Mark L Hatzenbuehler; Katherine Keyes; Elizabeth Ogburn
Journal:  Addiction       Date:  2006-09       Impact factor: 6.526

3.  A re-analysis of the reliability of psychiatric diagnosis.

Authors:  R L Spitzer; J L Fleiss
Journal:  Br J Psychiatry       Date:  1974-10       Impact factor: 9.319

4.  Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.

Authors:  Deborah Hasin; Sharon Samet; Edward Nunes; Jakob Meydan; Karen Matseoane; Rachel Waxman
Journal:  Am J Psychiatry       Date:  2006-04       Impact factor: 18.112

5.  Clinical criteria for psychiatric diagnosis and DSM-III.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Am J Psychiatry       Date:  1975-11       Impact factor: 18.112

6.  A diagnostic interview: the schedule for affective disorders and schizophrenia.

Authors:  J Endicott; R L Spitzer
Journal:  Arch Gen Psychiatry       Date:  1978-07

7.  DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses.

Authors:  Darrel A Regier; William E Narrow; Diana E Clarke; Helena C Kraemer; S Janet Kuramoto; Emily A Kuhl; David J Kupfer
Journal:  Am J Psychiatry       Date:  2013-01       Impact factor: 18.112
  7 in total
  10 in total

Review 1.  DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders.

Authors:  Hans-Jürgen Möller; Borwin Bandelow; Michael Bauer; Harald Hampel; Sabine C Herpertz; Michael Soyka; Utako B Barnikol; Simone Lista; Emanuel Severus; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-26       Impact factor: 5.270

Review 2.  The development and maintenance of drug addiction.

Authors:  Roy A Wise; George F Koob
Journal:  Neuropsychopharmacology       Date:  2013-10-11       Impact factor: 7.853

3.  Greater Prevalence of Proposed ICD-11 Alcohol and Cannabis Dependence Compared to ICD-10, DSM-IV, and DSM-5 in Treated Adolescents.

Authors:  Tammy Chung; Jack Cornelius; Duncan Clark; Christopher Martin
Journal:  Alcohol Clin Exp Res       Date:  2017-07-24       Impact factor: 3.455

4.  Characterizing Anxiety Among Individuals Receiving Treatment for Alcohol and Substance Use Disorders.

Authors:  Lisa H Domenico; Ben Lewis; Mythili Hazarika; Sara Jo Nixon
Journal:  J Am Psychiatr Nurses Assoc       Date:  2017-11-10       Impact factor: 2.385

Review 5.  DSM-5 criteria for substance use disorders: recommendations and rationale.

Authors:  Deborah S Hasin; Charles P O'Brien; Marc Auriacombe; Guilherme Borges; Kathleen Bucholz; Alan Budney; Wilson M Compton; Thomas Crowley; Walter Ling; Nancy M Petry; Marc Schuckit; Bridget F Grant
Journal:  Am J Psychiatry       Date:  2013-08       Impact factor: 18.112

6.  Response to commentaries.

Authors:  Christopher S Martin; James W Langenbucher; Tammy Chung; Kenneth J Sher
Journal:  Addiction       Date:  2014-11       Impact factor: 6.526

7.  Chronic alcohol self-administration in monkeys shows long-term quantity/frequency categorical stability.

Authors:  Erich J Baker; Jonathan Farro; Steven Gonzales; Christa Helms; Kathleen A Grant
Journal:  Alcohol Clin Exp Res       Date:  2014-11       Impact factor: 3.455

8.  Is lower severity alcohol use disorder qualitatively different than more severe manifestations? An evaluation of multivariate symptom clusters.

Authors:  Allen J Bailey; Polly F Ingram; Lindy K Howe; Peter R Finn
Journal:  Addiction       Date:  2022-01-27       Impact factor: 7.256

Review 9.  Commonalities and Differences Across Substance Use Disorders: Phenomenological and Epidemiological Aspects.

Authors:  Dvora Shmulewitz; Emily R Greene; Deborah Hasin
Journal:  Alcohol Clin Exp Res       Date:  2015-09-01       Impact factor: 3.455

10.  N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats.

Authors:  Yannick Fotio; Roberto Ciccocioppo; Daniele Piomelli
Journal:  Psychopharmacology (Berl)       Date:  2020-10-10       Impact factor: 4.530
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.